Advertisement
SCYNEXIS, Inc.

SCYNEXIS, Inc. (SCYX) Stock Overview

Explore SCYNEXIS, Inc.’s financial performance, market position, analyst ratings, and future outlook.

SCYXNASDAQ
HealthcareMedical - Pharmaceuticals
$3.85
$0.04(1.05%)
U.S. Market opens in 54h 49m
Advertisement

SCYNEXIS, Inc. (SCYX)

Meyka AI Score

Z

Key Financials

Market Cap24.2M
P/E Ratio-1.05
EPS (TTM)$-3.42
ROE-0.57%
Fundamental Analysis

AI Price Forecasts

1 Month$0.88
3 Months$0.90
1 Year Target$0.25

SCYX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of SCYNEXIS, Inc. (SCYX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 30.02, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.25.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -1.05 and a market capitalization of 24.2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.05%
5-Day Change
-4.23%
1-Month Change
-29.36%
3-Month Change
-42.54%
6-Month Change
-18.09%
Year-to-Date (YTD) Change
-23.91%
1-Year Change
-34.63%
3-Year Change
-82.81%
5-Year Change
-94.06%
All-Time (Max) Change
-99.47%

Contact Information

201 884 5485
1 Evertrust Plaza, Jersey City, NJ, 07302-6548

Company Facts

180 Employees
IPO DateMay 2, 2014
CountryUS
Actively Trading

Frequently Asked Questions